For the quarter ending 2026-03-31, NVCR made $174,055K in revenue. -$71,138K in net income. Net profit margin of -40.87%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net revenues | 174,055 | 174,350 | 167,204 | 158,805 |
| Cost of revenues | 38,929 | 42,157 | 44,729 | 41,472 |
| Gross profit | 135,126 | 132,193 | 122,475 | 117,333 |
| Research, development and clinical studies | 58,336 | 60,905 | 54,029 | 55,833 |
| Sales and marketing | 58,357 | 68,660 | 58,546 | 57,066 |
| General and administrative | 85,853 | 43,021 | 45,921 | 43,955 |
| Total operating costs and expenses | 202,546 | 172,586 | 158,496 | 156,854 |
| Operating income (loss) | -67,420 | -40,393 | -36,021 | -39,521 |
| Financial income (expenses), net | -1,838 | -561 | 5,999 | 4,542 |
| Income (loss) before income tax | -69,258 | -40,954 | -30,022 | -34,979 |
| Income tax | 1,880 | -16,455 | 7,248 | 5,160 |
| Net income (loss) | -71,138 | -24,499 | -37,270 | -40,139 |
| Basic EPS | -0.62 | -0.218 | -0.33 | -0.36 |
| Diluted EPS | -0.62 | -0.218 | -0.33 | -0.36 |
| Basic Average Shares | 114,149,838 | 112,125,689 | 111,908,252 | 111,572,191 |
| Diluted Average Shares | 114,149,838 | 112,125,689 | 111,908,252 | 111,572,191 |
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)